These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

933 related articles for article (PubMed ID: 28596092)

  • 41. Lung stereotactic body radiation therapy (SBRT) for early-stage non-small cell lung cancer in the very elderly (≥80years old): Extremely safe and effective.
    Kreinbrink P; Blumenfeld P; Tolekidis G; Sen N; Sher D; Marwaha G
    J Geriatr Oncol; 2017 Sep; 8(5):351-355. PubMed ID: 28739159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non-Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis.
    Wen SW; Han L; Lv HL; Xu YZ; Li ZH; Wang MB; Zhu YG; Su P; Tian ZQ; Zhang YF
    J Invest Surg; 2019 Jan; 32(1):27-34. PubMed ID: 28985095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline.
    Likhacheva A; Awan M; Barker CA; Bhatnagar A; Bradfield L; Brady MS; Buzurovic I; Geiger JL; Parvathaneni U; Zaky S; Devlin PM
    Pract Radiat Oncol; 2020; 10(1):8-20. PubMed ID: 31831330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
    Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy.
    Crabtree TD; Puri V; Robinson C; Bradley J; Broderick S; Patterson GA; Liu J; Musick JF; Bell JM; Yang M; Meyers BF
    J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1183-1191; discussion 1191-2. PubMed ID: 24507980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiation Therapy for Stage I Nonoperable or Medically Inoperable Lung Cancer.
    Kishan AU; Lee P
    Semin Respir Crit Care Med; 2016 Oct; 37(5):716-726. PubMed ID: 27732993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereotactic Body Radiation Therapy Versus Surgery for Early Lung Cancer Among US Veterans.
    Bryant AK; Mundt RC; Sandhu AP; Urbanic JJ; Sharabi AB; Gupta S; Daly ME; Murphy JD
    Ann Thorac Surg; 2018 Feb; 105(2):425-431. PubMed ID: 29198624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What do radiation oncologists require for future advancements in lung SBRT?
    Ricardi U; Badellino S; Filippi AR
    Phys Med; 2017 Dec; 44():150-156. PubMed ID: 27914779
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.
    Rodrigues G; Choy H; Bradley J; Rosenzweig KE; Bogart J; Curran WJ; Gore E; Langer C; Louie AV; Lutz S; Machtay M; Puri V; Werner-Wasik M; Videtic GMM
    Pract Radiat Oncol; 2015; 5(3):149-155. PubMed ID: 25957185
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Understanding patients' values and preferences regarding early stage lung cancer treatment decision making.
    Sullivan DR; Eden KB; Dieckmann NF; Golden SE; Vranas KC; Nugent SM; Slatore CG
    Lung Cancer; 2019 May; 131():47-57. PubMed ID: 31027697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The patient's perspective on stereotactic body radiation therapy (SBRT) vs. surgery for treatment of early stage non-small cell lung cancer (NSCLC).
    Shaverdian N; Wang PC; Steinberg M; Lee P
    Lung Cancer; 2015 Nov; 90(2):230-3. PubMed ID: 26358313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy.
    Ernani V; Appiah AK; Baine MJ; Smith LM; Ganti AK
    Cancer Treat Res Commun; 2020; 24():100197. PubMed ID: 32777751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stereotactic Body Radiation Therapy Versus Nonradiotherapeutic Ablative Procedures (Laser/Cryoablation and Electrocautery) for Early-Stage Non-Small Cell Lung Cancer.
    Baine MJ; Sleightholm R; Neilsen BK; Oupický D; Smith LM; Verma V; Lin C
    J Natl Compr Canc Netw; 2019 May; 17(5):450-458. PubMed ID: 31085762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrence After Stereotactic Body Radiation Therapy Versus Lobectomy for Non-Small Cell Lung Cancer.
    Sebastian NT; Merritt RE; Abdel-Rasoul M; Wu T; Bazan JG; Xu-Welliver M; Haglund K; D'Souza D; Kneuertz PJ; Williams TM
    Ann Thorac Surg; 2020 Sep; 110(3):998-1005. PubMed ID: 32353436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Definitive treatment patterns and survival in stage II non-small cell lung cancer.
    Yan SX; Qureshi MM; Suzuki K; Dyer M; Truong MT; Litle V; Mak KS
    Lung Cancer; 2018 Oct; 124():135-142. PubMed ID: 30268452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Novel Neoadjuvant Therapy for Operable Locally Invasive Non-Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574).
    Nguyen NA; Isfahanian N; Pond G; Hanna W; Cutz JC; Wright J; Swaminath A; Shargall Y; Chow T; Wierzbicki M; Okawara G; Quan K; Finley C; Juergens R; Tsakiridis T
    Clin Lung Cancer; 2017 Jul; 18(4):436-440.e1. PubMed ID: 28215851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison Between Stereotactic Radiotherapy and Sublobar Resection for Non-Small Cell Lung Cancer.
    Tamura M; Matsumoto I; Tanaka Y; Saito D; Yoshida S; Kakegawa S; Kumano T; Shimizu Y; Tamamura H; Takanaka T; Takemura H
    Ann Thorac Surg; 2019 May; 107(5):1544-1550. PubMed ID: 30458155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.
    Nagata Y; Hiraoka M; Shibata T; Onishi H; Kokubo M; Karasawa K; Shioyama Y; Onimaru R; Kozuka T; Kunieda E; Saito T; Nakagawa K; Hareyama M; Takai Y; Hayakawa K; Mitsuhashi N; Ishikura S
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):989-96. PubMed ID: 26581137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy.
    Rwigema JC; Chen AM; Wang PC; Lee JM; Garon E; Lee P
    Clin Lung Cancer; 2014 Jul; 15(4):287-93. PubMed ID: 24594401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cost-effectiveness of stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
    Shah A; Hahn SM; Stetson RL; Friedberg JS; Pechet TT; Sher DJ
    Cancer; 2013 Sep; 119(17):3123-32. PubMed ID: 23720093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.